SEC Form 4 insider trading filings tracked in real time from EDGAR

van Houte Hans — Chief Financial Officer

Insider trading activity for van Houte Hans sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: Nurix Therapeutics, Inc.
  • Total insider trades: 7
  • Total buy volume: $0
  • Total sell volume: $40K
  • Last trade: Apr 30, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. OTHER 2,858 N/A
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. OTHER 3,750 N/A
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. OTHER 2,000 N/A
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. SELL 2,388 $40K
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. OTHER 2,858 N/A
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. OTHER 3,750 N/A
Apr 30, 2026 van Houte Hans NRIX Nurix Therapeutics, Inc. OTHER 2,000 N/A

← All executives · Full trades feed